Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Sales | 425,892 | 408,728 | 373,744 | 357,188 | 322,383 |
| Cost of Goods | 113,207 | 115,994 | 104,454 | 94,884 | 85,634 |
| Gross Profit | 285,969 | 292,734 | 269,290 | 262,304 | 236,749 |
| Operating Expenses | 178,325 | 168,006 | 164,569 | 148,072 | 130,427 |
| Operating Income | 134,567 | 125,722 | 105,175 | 115,116 | 106,956 |
| Interest Expense | 3,282 | 3,202 | 3,490 | 3,202 | 1,290 |
| Other Income | -22,913 | -8,751 | 838 | -64,093 | -72,808 |
| Pre-tax Income | 108,372 | 113,769 | 102,523 | 47,821 | 32,858 |
| Income Tax | 35,763 | 37,025 | 34,680 | 24,311 | 33,849 |
| Net Income Continuous | 68,518 | 76,744 | 67,843 | 23,510 | -991 |
| Net Income | $68,518 | $76,744 | $67,843 | $23,510 | $-991 |
| EPS Basic Total Ops | 0.10 | 0.11 | 0.09 | 0.03 | 0.00 |
| EPS Basic Continuous Ops | 0.09 | 0.10 | 0.09 | 0.03 | 0.00 |
| EPS Diluted Total Ops | 0.09 | 0.11 | 0.09 | 0.03 | 0.00 |
| EPS Diluted Continuous Ops | 0.09 | 0.10 | 0.09 | 0.03 | 0.00 |
| EBITDA(a) | $134,567 | $187,122 | $105,175 | $115,116 | $106,956 |